Praxis Precision Medicines (PRAX) Stock Forecast & Price Target $52.72 +0.38 (+0.72%) As of 03:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Praxis Precision Medicines - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating Moderate BuyBased on 12 Analyst RatingsSell2Hold0Buy10 Based on 12 Wall Street analysts who have issued ratings for Praxis Precision Medicines in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 2 have given a sell rating, 9 have given a buy rating, and 1 has given a strong buy rating for PRAX. Consensus Price Target $85.5662.30% Upside According to the 12 analysts' twelve-month price targets for Praxis Precision Medicines, the average price target is $85.56. The highest price target for PRAX is $115.00, while the lowest price target for PRAX is $28.00. The average price target represents a forecasted upside of 62.30% from the current price of $52.72. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for PRAX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Praxis Precision Medicines and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRAX Analyst Ratings Over TimeTypeCurrent Forecast10/14/24 to 10/14/251 Month Ago9/14/24 to 9/14/253 Months Ago7/16/24 to 7/16/251 Year Ago10/15/23 to 10/14/24Strong Buy1 Strong Buy rating(s)1 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy9 Buy rating(s)8 Buy rating(s)8 Buy rating(s)8 Buy rating(s)Hold0 Hold rating(s)0 Hold rating(s)0 Hold rating(s)1 Hold rating(s)Sell2 Sell rating(s)1 Sell rating(s)1 Sell rating(s)0 Sell rating(s)Consensus Price Target$85.56$85.88$94.11$143.44Forecasted Upside62.30% Upside127.72% Upside75.48% Upside104.80% UpsideConsensus RatingModerate BuyModerate BuyModerate BuyModerate Buy PRAX Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History PRAX Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Praxis Precision Medicines Stock vs. The CompetitionTypePraxis Precision MedicinesMedical CompaniesS&P 500Consensus Rating Score 2.75 2.33 2.52Consensus RatingModerate BuyHoldModerate BuyPredicted Upside63.46% Upside1,037.22% Upside14.04% UpsideNews Sentiment RatingPositive NewsSee Recent PRAX NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails10/8/2025Weiss Ratings0 of 5 stars Reiterated RatingSell (D-)9/18/2025Jones Trading0 of 5 starsJustin Walsh Not RatedInitiated CoverageBuy$83.00+88.51%9/3/2025Lifesci Capital3 of 5 stars UpgradeStrong-Buy9/2/2025Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingBuy8/5/2025HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDouglas TsaoSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingBuy$105.00 ➝ $115.00+125.09%7/29/2025Chardan CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingRudy LiSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingBuy$80.00+43.76%7/8/2025OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJay OlsonSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOutperform$97.00 ➝ $115.00+147.90%6/12/2025Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAmi FadiaSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingBuy$80.00+79.37%5/5/2025WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingL. ChicoSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetUnderperform$26.00 ➝ $28.00-29.93%3/3/2025Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJoon LeeSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetBuy$175.00 ➝ $85.00+125.40% Get the Latest News and Ratings for PRAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Praxis Precision Medicines and its competitors with MarketBeat's FREE daily newsletter. 3/3/2025Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJoel BeattySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetOutperform$117.00 ➝ $73.00+89.12%2/11/2025Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDavid HoangSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingInitiated CoverageBuy$111.00+30.82%8/14/2024GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingY. SunejaSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetBuy$155.00 ➝ $170.00+228.63%7/1/2024Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingOverweight$270.00 ➝ $270.00+558.54%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 03:46 PM ET. PRAX Forecast - Frequently Asked Questions What is Praxis Precision Medicines' forecast for 2025? According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Praxis Precision Medicines is $85.56, with a high forecast of $115.00 and a low forecast of $28.00. Should I buy or sell Praxis Precision Medicines stock right now? 12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Praxis Precision Medicines in the last year. There are currently 2 sell ratings, 9 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PRAX shares. Does Praxis Precision Medicines's stock price have much upside? According to analysts, Praxis Precision Medicines's stock has a predicted upside of 62.30% based on their 12-month stock forecasts. Has Praxis Precision Medicines been upgraded by Wall Street analysts recently? Over the previous 90 days, Praxis Precision Medicines's stock had 1 upgrade by analysts. What analysts cover Praxis Precision Medicines? Praxis Precision Medicines has been rated by research analysts at Chardan Capital, HC Wainwright, Jefferies Financial Group, Jones Trading, Lifesci Capital, and Weiss Ratings in the past 90 days. Do Wall Street analysts like Praxis Precision Medicines more than its competitors? Analysts like Praxis Precision Medicines more than other "medical" companies. The consensus rating for Praxis Precision Medicines is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how PRAX compares to other companies. Stock Forecasts and Research Tools Related Companies Kymera Therapeutics Stock Forecast Protagonist Therapeutics Stock Forecast Crinetics Pharmaceuticals Stock Forecast Zai Lab Stock Forecast Akero Therapeutics Stock Forecast ACADIA Pharmaceuticals Stock Forecast Ascentage Pharma Group International Stock Forecast Mirum Pharmaceuticals Stock Forecast Lantheus Stock Forecast Jyong Biotech Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:PRAX) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBlackRock’s Shocking Crypto MoveBlackRock, Fidelity, and JPMorgan have quietly shifted billions out of Bitcoin and into a single emerging cryp...Weiss Ratings | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Praxis Precision Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Praxis Precision Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
